More on Perkin Elmer (PKI): Q3 beats across the board on strong revenue growth out of its human-health focused segment. Net profit declined 19% however, due largely to lower contributions from businesses that the company has sold. For FY12, the company raises its per-share earnings estimate to $2.05 to $2.07, up from its prior estimate for $2 to $2.05, and reiterated its forecast for organic revenue growth.
More on Perkin Elmer (PKI): Q3 beats across the board on strong revenue growth out of its...
From other sites
at CNBC.com (May 5, 2014)
at CNBC.com (Apr 23, 2014)
at CNBC.com (Jan 29, 2014)
at CNBC.com (Dec 17, 2013)
at CNBC.com (Sep 16, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs